Novel functions of human α1-protease inhibitor after S-nitrosylation:: Inhibition of cysteine protease and antibacterial activity

被引:40
作者
Miyamoto, Y
Akaike, T
Alam, MS
Inoue, K
Hamamoto, T
Ikebe, N
Yoshitake, J
Okamoto, T
Maeda, H [1 ]
机构
[1] Kumamoto Univ, Sch Med, Dept Microbiol, Kumamoto 8600811, Japan
[2] ChemoSero Therapeut Inst, Kumamoto 8600083, Japan
关键词
D O I
10.1006/bbrc.1999.2046
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
alpha(1)-Protease inhibitor (alpha(1)PI), the most abundant serine protease inhibitor found in human plasma (at 30-60 mu M) is a glycoprotein (53 kDa) having a single cysteine residue at position 232 (Cys(232)). We have found that Cys232 of human alpha(1)PI was readily S-nitrosylated by nitric oxide (NO) without affecting inhibitory activity to trypsin or elastase. S-nitrosylated alpha(1)PI (S-NO-alpha(1)PI) not only retained inhibitory activity against these serine proteases, but also gained thiol protease inhibitory activity against a Streptococcus pyrogenes protease; the parental alpha(1)PI did not have this activity. Furthermore, S-NO-alpha(1)PI exhibited bacteriostatic activity against Salmonella typhimurium at concentrations of 0.1-10 mu M which were 20- to 3000-fold stronger than those of the other NO-generating compounds or S-nitroso compounds such as S-nitrosoalbumin and S-nitrosoglutathione. NO appears to be transferred into the bacterial cells from S-NO-alpha(1)PI via transnitrosylation, as evidenced by electron spin resonance spectroscopy with an NO spin trap. Thus, we conclude that S-NO-alpha(1)PI may be generated from the reaction between alpha(1)PI and NO under inflammatory conditions, in which production Of both is known to increase. As a result, new functions, i.e., antibacterial and thiol protease inhibitory activities of alpha(1)PI, were generated. (C) 2000 Academic Press.
引用
收藏
页码:918 / 923
页数:6
相关论文
共 31 条
[1]  
Akaike T, 1997, J BIOCHEM-TOKYO, V122, P459
[2]  
BEVILLARD P, 1957, B SOC CHIM FR, P337
[3]  
BOSTIAN KA, 1976, J LAB CLIN MED, V87, P577
[4]   STRUCTURE AND VARIATION OF HUMAN ALPHA-1-ANTITRYPSIN [J].
CARRELL, RW ;
JEPPSSON, JO ;
LAURELL, CB ;
BRENNAN, SO ;
OWEN, MC ;
VAUGHAN, L ;
BOSWELL, DR .
NATURE, 1982, 298 (5872) :329-334
[5]   Temporal production of streptococcal erythrogenic toxin B (streptococcal cysteine proteinase) in response to nutrient depletion [J].
Chaussee, MS ;
Phillips, ER ;
Ferretti, JJ .
INFECTION AND IMMUNITY, 1997, 65 (05) :1956-1959
[6]  
CHRETIEN A, 1945, CR HEBD ACAD SCI, V220, P746
[7]   GENETIC AND REDOX DETERMINANTS OF NITRIC-OXIDE CYTOTOXICITY IN A SALMONELLA-TYPHIMURIUM MODEL [J].
DEGROOTE, MA ;
GRANGER, D ;
XU, YS ;
CAMPBELL, G ;
PRINCE, R ;
FANG, FC .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (14) :6399-6403
[8]   Homocysteine antagonism of nitric oxide-related cytostasis in Salmonella typhimurium [J].
DeGroote, MA ;
Testerman, T ;
Xu, YS ;
Stauffer, G ;
Fang, FC .
SCIENCE, 1996, 272 (5260) :414-417
[9]  
Ewing JF, 1997, J PHARMACOL EXP THER, V283, P947
[10]   Role of nitric oxide in pathogenesis of herpes simplex virus encephalitis in rats [J].
Fujii, S ;
Akaike, T ;
Maeda, H .
VIROLOGY, 1999, 256 (02) :203-212